title: Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Lilleby
authors.forename: Karol
authors.initials: K
authors.lastname: Axcrona
authors.forename: G Cecilie
authors.initials: GC
authors.lastname: Alfsen
authors.forename: Thomas
authors.initials: T
authors.lastname: Urnes
authors.forename: Knut H
authors.initials: KH
authors.lastname: Hole
mesh_terms: D000359:Aftercare; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009376:Neoplasms, Hormone-Dependent / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D020266:Radiotherapy, Conformal
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin